J1190 Dexrazoxane hcl injection
Also known as: Zinecard, dexrazoxane
Dexrazoxane hydrochloride injection, a cardioprotective agent for prevention of chemotherapy-induced cardiomyopathy.
In Plain Language
Heart protection from cancer drugs
Clinical Context
Used for cardioprotection in patients receiving anthracycline chemotherapy to reduce risk of cardiomyopathy and congestive heart failure.
RVU Information
CPT J1190 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1190?
CPT J1190 (Dexrazoxane hcl injection) is a J Codes (Drugs) code. Dexrazoxane hydrochloride injection, a cardioprotective agent for prevention of chemotherapy-induced cardiomyopathy.
How is J1190 administered?
CPT J1190 is administered by a healthcare provider, typically via injection or infusion. Used for cardioprotection in patients receiving anthracycline chemotherapy to reduce risk of cardiomyopathy and congestive heart failure. It is used by Oncology, Cardiology, Internal Medicine.
When is CPT J1190 used?
Used for cardioprotection in patients receiving anthracycline chemotherapy to reduce risk of cardiomyopathy and congestive heart failure.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.